Avantax Advisory Services, Inc. Kezar Life Sciences, Inc. Transaction History
Avantax Advisory Services, Inc.
- $14.9 Billion
- Q3 2024
A detailed history of Avantax Advisory Services, Inc. transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 11,110 shares of KZR stock, worth $70,437. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,110
Previous 11,110
-0.0%
Holding current value
$70,437
Previous $6,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding KZR
# of Institutions
59Shares Held
38.2MCall Options Held
13.8KPut Options Held
600-
Suvretta Capital Management, LLC New York, NY7.17MShares$45.4 Million0.22% of portfolio
-
Avidity Partners Management LP Dallas, TX5.03MShares$31.9 Million0.24% of portfolio
-
Tang Capital Management LLC San Diego, CA3.64MShares$23.1 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.74MShares$17.4 Million0.0% of portfolio
-
Affinity Asset Advisors, LLC New York, NY2.51MShares$15.9 Million0.33% of portfolio
About Kezar Life Sciences, Inc.
- Ticker KZR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,369,504
- Market Cap $433M
- Description
- Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...